SG 461 Pill - blue oval, 13mm
Pill with imprint SG 461 is Blue, Oval and has been identified as Carbidopa and Levodopa Extended-Release 50 mg / 200 mg. It is supplied by ScieGen Pharmaceuticals Inc.
Carbidopa/levodopa is used in the treatment of Parkinson's Disease; Neuroleptic Malignant Syndrome; GTP-CH Deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SG 461
Carbidopa and Levodopa Extended-Release
- Imprint
- SG 461
- Strength
- 50 mg / 200 mg
- Color
- Blue
- Size
- 13.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ScieGen Pharmaceuticals Inc.
- National Drug Code (NDC)
- 50228-0461
More about carbidopa / levodopa
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (92)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
- Carbidopa and levodopa drug information
- Carbidopa and levodopa enteral
- Carbidopa and levodopa () (Advanced Reading)
- Carbidopa and levodopa (Oral) (Advanced Reading)
- Carbidopa and Levodopa Extended-Release Capsules
Other brands
Sinemet, Rytary, Sinemet CR, Crexont, ... +3 more
Professional resources
- Levodopa/Carbidopa monograph
- Carbidopa and Levodopa (FDA)
- Carbidopa and Levodopa ODT (FDA)
- Carbidopa and Levodopa Tablets (FDA)
Other brands
Sinemet, Rytary, Sinemet CR, Crexont, ... +3 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
